𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P158 Alemtuzumab for the treatment of hairy cell leukemia and atypical hairy cell leukemia variant; report of two cases

✍ Scribed by B. Telek; P. Batar; L. Rejto; M. Udvardy

Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
51 KB
Volume
21
Category
Article
ISSN
0268-960X

No coin nor oath required. For personal study only.

✦ Synopsis

immunmodulant therapy was begun. We started steroid, cyclosporine and thalidomide therapy. The control abdominal and pelvic CT showed small residual tumor on the bladder. Repeated surgery was done, residual was taken out. At this time histological examination showed transient type between plasma cell and vascular variant. Now almost 3 years after onset of the disease with low dose steroid, cyclosporine and thalidomide therapy our patient does not have any symptoms or complaints. Conclusion: Castleman disease can be successfully treated with immunmodulant therapy.

πŸ“œ SIMILAR VOLUMES

Hairy cell leukemiaβ€”mediastinal involvem
Hairy cell leukemiaβ€”mediastinal involvement. A report of two cases and review of the literature
✍ S. T. A. Malik; J. Amess; A. J. D'Ardenne; T. A. Lister πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 778 KB

The clinical features of two patients with hairy cell leukemia involving the mediastinum are described. Both patients presented with acute chest pain 2-3 months prior to diagnosis being made. In one patient mediastindl disease was recorded only by computerized tomography of the thorax. There was goo

Interferon alpha in the treatment of hai
Interferon alpha in the treatment of hairy cell leukemia
✍ Sylvie Castaigne; FranΓ§ois Sigaux; Kari Cantell; Ernesto Falcoff; Michel Boiron; πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 336 KB πŸ‘ 2 views